Searchable abstracts of presentations at key conferences in endocrinology

ea0016p467 | Neuroendocrinology | ECE2008

Starting dose of 10 mg Octreotide-LAR appears ineffective for biochemical control in the majority of acromegalic patients: interim analysis from the OASIS trial

Petersenn Stephan , Tarasov Alexander , Gu Feng , Kim Sungwoon , Mercado Moises , Rogozinski Amelia , Bouterfa Hakim , David Kristin , Silva Antonio , Greenman Yona

Octreotide LAR (SMS-LAR) is available in 10, 20 and 30 mg dosing. The relation-ship between SMS-LAR starting dose and GH, IGF-I and symptoms was exam-ined. The Observational Acromegaly Study on Impact of Sandostatin LAR (OASIS) collects data on GH, IGF-I, symptoms, safety and tolerability in recently diagnosed acromegalic patients. Data are collected under normal practice conditions over 12 mos. Eight hundred and sixty patients from 138 centers in 23 countries are enrolled; 35...

ea0090ep799 | Pituitary and Neuroendocrinology | ECE2023

Craniopharyngiomas in adult patients: Retrospective, multicentric study in Buenos Aires, Argentina

Mallea-Gil Susana , Glerean Mariela , Rogozinski Amelia , Ballarino Carolina , Battistone Maria Florencia , Danilowicz Karina , Diez Sabrina , Day Patricia Fainstein , Furioso Alejandra , Guitelman Mirtha , Katz Debora , Loto Monica , Martinez Marcela , Miragaya Karina , Sosa Soledad , Slavinsky Patricia , Tkatch Julieta , Vitale Marcelo , Pernas Valeria Gonzalez , Roel Valeria Garcia , Pingel Jesica

Craniopharyngiomas are rare lesions derived from cell remnants of Rathke’s pouch, usually localized in the sellar and suprasellar areas.Objectives: To analyze clinical, endocrine and histological features in a group of patients from Buenos Aires city. To assess efficacy, number of surgeries and complications after surgery or other treatments.Material and methods: Multicentric, retrospective, transversal study. Adult patients w...